Purnuo Intelligent Medicine

Purnuo Intelligent Medicine is a biotechnology company based in Beijing, China, that specializes in AI-driven drug discovery and development. The company utilizes an advanced computational platform that integrates artificial intelligence with structural biology and medicinal chemistry to identify novel therapeutics for challenging and "undruggable" targets. Its primary research focus spans oncology, autoimmune disorders, and metabolic diseases, aiming to streamline the transition from target identification to clinical candidate selection. By leveraging high-performance computing and proprietary algorithms, Purnuo seeks to significantly improve the efficiency and success rates of small molecule drug development. The firm has successfully raised capital from prominent venture investors to advance its internal pipeline and technological infrastructure.